James Emmett Young, the Chief Financial Officer of TriSalus Life Sciences, Inc. (NASDAQ:TLSI), has acquired 6,000 shares of the company's common stock, according to a recent filing with the Securities ...
Chief Operating Officer, Daniel LeSueur, executed a sale of company shares, as detailed in a recent SEC filing. On February 5, LeSueur sold 5,209 shares of common stock at an average price of $5.7607 ...